Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DiaSorin S.p.A.

DSRLF
Current price
107.88 USD 0 USD (0.00%)
Last closed 107.1 EUR
ISIN IT0003492391
Sector Healthcare
Industry Diagnostics & Research
Exchange MI
Capitalization 5 720 373 292 EUR
Yield for 12 month +22.55 %
1Y
3Y
5Y
10Y
15Y
DSRLF
21.11.2021 - 28.11.2021

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy. Address: Via Crescentino, Saluggia, VC, Italy, 13040

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

93.21 EUR

P/E ratio

35.3465

Dividend Yield

1.07 %

Current Year

+1 150 269 200 EUR

Last Year

+1 363 579 066 EUR

Current Quarter

+300 744 390 EUR

Last Quarter

+289 518 293 EUR

Current Year

+670 282 934 EUR

Last Year

+902 228 159 EUR

Current Quarter

+198 287 973 EUR

Last Quarter

+192 344 333 EUR

Key Figures DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 368 615 604 EUR
Operating Margin TTM 21.6 %
PE Ratio 35.3465
Return On Assets TTM 6.07 %
PEG Ratio 1.5184
Return On Equity TTM 11.85 %
Wall Street Target Price 93.21 EUR
Revenue TTM 1 180 323 051 EUR
Book Value 30.25 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6.3 %
Dividend Yield 1.07 %
Gross Profit TTM 902 228 160 EUR
Earnings per share 3.04 EUR
Diluted Eps TTM 3.04 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 7.7 %
Profit Margin 16.03 %

Dividend Analytics DSRLF

Dividend growth over 5 years

29 %

Continuous growth

2 years

Payout Ratio 5 years average

31 %

Dividend History DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.15
Ex Dividend Date 20.05.2024
Forward Annual Dividend Yield 1.13 %
Last Split Factor
Payout Ratio 43.23 %
Last Split Date
Dividend Date

Stock Valuation DSRLF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 35.3465
Forward PE 23.2558
Enterprise Value Revenue 5.5358
Price Sales TTM 4.8464
Enterprise Value EBITDA 25.8259
Price Book MRQ 3.5335

Financials DSRLF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DSRLF

For 52 weeks

81.93 EUR 112.55 EUR
50 Day MA 103.23 EUR
Shares Short Prior Month
200 Day MA 97.41 EUR
Short Ratio
Shares Short
Short Percent